Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Schipperus

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Netherlands Journal of Medicine|October 24, 2007
Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the NetherlandsB A P Laros-van Gorkom, C A M Huisman, P W Wijermans, et al.
The British Journal of Surgery|September 6, 2000
Diagnosis and treatment of portal vein thrombosis following splenectomyM van't Riet, J W Burger, J M van Muiswinkel, et al.
Vox Sanguinis|January 6, 2015
Presence of medication taken by blood donors in plasma for transfusionA J W van Tilborgh-de Jong, J C Wiersum-Osselton, D J Touw, et al.
Transfusion Medicine (Oxford, England)|March 27, 2004
Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemiaA J G Jansen, M A A Caljouw, W C J Hop, et al.
Vox Sanguinis|October 16, 2012
Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practiceJ C Wiersum-Osselton, J C Faber, C Politis, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 30, 2008
[Transfusion-related acute lung injury (TRALI) in the Netherlands in 2002-2005]J C Wiersum-Osselton, L Porcelijn, D van Stein, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 21, 2008
Duration of meconium passage in preterm and term infantsN Bekkali, S L Hamers, M R Schipperus, et al.
Vox Sanguinis|April 23, 2015
Quality indicators for the hospital transfusion chain: a national survey conducted in 100 dutch hospitalsP Y Zijlker-Jansen, M P Janssen, A J W van Tilborgh-de Jong, et al.
British Journal of Haematology|April 16, 2003
Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromesA J G Jansen, M-L Essink-Bot, E A M Beckers, et al.
Vox Sanguinis|November 5, 2011
Treatment of primary autoimmune thrombocytopenia (AITP) [1]M R Schipperus, R Fijnheer, I Pabinger, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Netherlands Journal of Medicine|October 24, 2007
Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the NetherlandsB A P Laros-van Gorkom, C A M Huisman, P W Wijermans, et al.
The British Journal of Surgery|September 6, 2000
Diagnosis and treatment of portal vein thrombosis following splenectomyM van't Riet, J W Burger, J M van Muiswinkel, et al.
Vox Sanguinis|January 6, 2015
Presence of medication taken by blood donors in plasma for transfusionA J W van Tilborgh-de Jong, J C Wiersum-Osselton, D J Touw, et al.
Transfusion Medicine (Oxford, England)|March 27, 2004
Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemiaA J G Jansen, M A A Caljouw, W C J Hop, et al.
Vox Sanguinis|October 16, 2012
Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practiceJ C Wiersum-Osselton, J C Faber, C Politis, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 30, 2008
[Transfusion-related acute lung injury (TRALI) in the Netherlands in 2002-2005]J C Wiersum-Osselton, L Porcelijn, D van Stein, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 21, 2008
Duration of meconium passage in preterm and term infantsN Bekkali, S L Hamers, M R Schipperus, et al.
Vox Sanguinis|April 23, 2015
Quality indicators for the hospital transfusion chain: a national survey conducted in 100 dutch hospitalsP Y Zijlker-Jansen, M P Janssen, A J W van Tilborgh-de Jong, et al.
British Journal of Haematology|April 16, 2003
Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromesA J G Jansen, M-L Essink-Bot, E A M Beckers, et al.
Vox Sanguinis|November 5, 2011
Treatment of primary autoimmune thrombocytopenia (AITP) [1]M R Schipperus, R Fijnheer, I Pabinger, et al.
Pageof 3